Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
Trial record 1 of 1 for:    Estrogen Receptor-beta phytoSERMs for Management
Previous Study | Return to List | Next Study

Phytoserms for Menopause Symptoms and Age-Associated Memory Decline (phytoSERM)

This study has been completed.
Sponsor:
Collaborator:
National Institute on Aging (NIA)
Information provided by (Responsible Party):
University of Southern California
ClinicalTrials.gov Identifier:
NCT01723917
First received: November 6, 2012
Last updated: January 13, 2015
Last verified: January 2015

November 6, 2012
January 13, 2015
July 2012
January 2015   (Final data collection date for primary outcome measure)
  • safety and tolerability [ Time Frame: 12 weeks ]
    as measured by assessment of AEs, co-morbid events, laboratory measures, symptoms and cognitive performance
  • efficacy [ Time Frame: 12 weeks ]
    change from baseline in neuropsychological (cognitive, functional) test results
  • efficacy [ Time Frame: 12 weeks ]
    change from baseline in vasomotor symptoms
Same as current
Complete list of historical versions of study NCT01723917 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Phytoserms for Menopause Symptoms and Age-Associated Memory Decline
Estrogen Receptor-beta phytoSERMs for Management of Menopause and Age-Associated Memory Decline
The purpose of this study is to evaluate the safety and efficacy of a soy based dietary supplement (phytoSERM) for hot flashes and age associated memory loss.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)
  • Hot Flashes
  • Memory Loss
  • Dietary Supplement: PhytoSERM tablet
  • Dietary Supplement: placebo
  • Experimental: PhytoSERM 50 mg tablet
    Dietary supplement: PhytoSERM tablet to be taken once per day for 12 weeks
    Intervention: Dietary Supplement: PhytoSERM tablet
  • Experimental: PhytoSERM 100 mg tablet
    Dietary supplement: PhytoSERM tablet to be taken once per day for 12 weeks
    Intervention: Dietary Supplement: PhytoSERM tablet
  • Placebo Comparator: Placebo tablet
    Dietary supplement: placebo tablet to be taken once per day for 12 weeks
    Intervention: Dietary Supplement: placebo
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
71
January 2015
January 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • post-menopausal women
  • ages 48 - 58 (inclusive)
  • must have a vasomotor symptom (e.g., hot flash) and a memory complaint

Exclusion Criteria:

  • history of clinically significant stroke
  • current evidence or history in past 2 years of epilepsy, seizure, focal brain lesion, head injury with loss of consciousness or any major psychiatric disorder including psychosis, major depression, bipolar disorder, alcohol or substance abuse
  • Known allergy to soy derived products; hypersensitivity to estrogens or progestins
Sexes Eligible for Study: Female
48 Years to 58 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01723917
AG033288
R01AG033288 ( US NIH Grant/Contract Award Number )
Yes
Not Provided
Not Provided
Not Provided
University of Southern California
University of Southern California
National Institute on Aging (NIA)
Principal Investigator: Lon S Schneider, MD University of Southern California
University of Southern California
January 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP